🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 11 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/09/2000 43,13 46,00 43,00 44,81 +2,72% 6,96% 114.200
19/09/2000 42,94 43,81 42,88 43,63 +0,43% 2,18% 209.400
18/09/2000 44,44 44,50 42,50 43,44 -1,84% 4,50% 129.600
15/09/2000 43,53 45,00 43,50 44,25 -1,12% 3,45% 77.000
14/09/2000 41,81 44,88 41,81 44,75 +5,60% 7,32% 196.000
13/09/2000 41,44 42,38 40,25 42,38 +0,89% 5,13% 46.200
12/09/2000 41,38 42,00 40,88 42,00 +1,97% 2,72% 130.000
11/09/2000 41,53 42,00 40,75 41,19 +0,30% 3,01% 121.500
08/09/2000 41,00 43,81 41,00 41,06 -2,23% 6,86% 166.800
07/09/2000 42,25 42,25 41,25 42,00 +1,51% 2,37% 106.500
06/09/2000 41,44 42,28 40,63 41,38 +0,00% 4,00% 144.800
05/09/2000 39,56 42,00 38,13 41,38 +0,76% 9,79% 299.900
01/09/2000 40,91 42,38 40,81 41,06 -0,76% 3,82% 455.600
31/08/2000 38,31 41,38 38,31 41,38 +9,06% 7,99% 326.800
30/08/2000 37,13 38,13 36,81 37,94 +2,53% 3,54% 49.600
29/08/2000 36,78 37,50 36,75 37,00 +2,03% 2,04% 36.400
28/08/2000 39,00 39,63 36,25 36,27 -6,11% 8,65% 221.700
25/08/2000 35,00 38,63 35,00 38,63 +8,80% 10,36% 127.400
24/08/2000 34,59 36,50 34,50 35,50 +1,97% 5,78% 94.200
23/08/2000 32,09 35,31 31,75 34,81 +5,89% 11,10% 272.400
22/08/2000 32,00 33,13 31,06 32,88 +4,99% 6,45% 178.100
21/08/2000 30,91 31,75 30,50 31,31 +0,20% 4,04% 61.200
18/08/2000 31,38 31,88 30,89 31,25 -4,76% 3,14% 22.400
17/08/2000 31,38 33,75 30,88 32,81 +0,96% 9,16% 102.800
16/08/2000 34,00 34,00 31,31 32,50 -4,10% 7,90% 116.300
15/08/2000 34,13 35,00 33,13 33,89 -3,00% 5,49% 35.700
14/08/2000 34,13 34,94 33,13 34,94 -0,89% 5,31% 64.300
11/08/2000 34,81 35,63 34,00 35,25 +0,00% 4,67% 139.200
10/08/2000 35,63 35,88 33,75 35,25 -1,74% 5,96% 310.200
09/08/2000 32,63 36,38 30,63 35,88 +10,38% 17,62% 657.000